Arbuckle Stuart A 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed May 15, 2025
Insider Transaction Report
Form 4
Arbuckle Stuart A
EVP\Chief Commercial Officer
Transactions
- Award
Common Stock
2025-05-13+37,622→ 100,611 total
Holdings
- 140(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]Represents earned performance shares with respect to a performance stock unit award granted on 12/06/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 05/13/2025 and the shares will vest on 07/01/2025.